Oncology information systems are digital systems designed to keep
track of the multi-pronged treatment patterns of cancer treatment.
Oncology information systems deal with various parts of cancer
treatment, including treatment planning and patient information
records. The global oncology information system market has exhibited
steady growth over the last few years due to key drivers such as the
rising prevalence of cancer across the world and the rising adoption
of digital resources in the healthcare sector. The global oncology
information system market is likely to exhibit a strong 7.6% CAGR
over the 2017-2022 forecast period, with its valuation set to rise
from US$2,285.6 mn in 2017 to US$3,293.8 mn in 2022.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18659
The rising prevalence of cancer across the world, and especially in
developed countries, is the key driver for the global oncology
information system market. The oncology information system market has
benefited from the steady growth of the cancer treatment research
sector in countries such as the U.S., Canada, Germany, and the U.K.
and is set to prosper in the coming years due to the growing
investment being provided to cancer research in these regions. The
growing incidence of cancer recurrence in these countries is likely
to be a crucial driver for the oncology information system market in
the coming years, as oncology information systems are most utile in
long-term cases that require consistent coordination with the
historical treatment patterns.
Government support to cancer research has also been forthcoming in
developed countries, while the growing adoption of unhealthy
lifestyle choices such as sedentary lifestyles, excessive consumption
of junk food, and preference to addictions such as smoking and
alcohol is likely to be a key driver for the global oncology
information system market in the coming years. Growing government
support is crucial for widespread adoption of oncology information
systems, as it helps enable universal adoption and eases the
financial load of incorporating the systems into the operating
mechanisms of smaller hospitals.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=18659
Accordingly, North America is set to remain the dominant contributor
to the global oncology information system market in the coming years.
The North America oncology information system market is set to rise
from a valuation of US$933.7 mn to US$1,411.5 mn over the 2017-2022
forecast period, making it the dominant geographical segment of the
global oncology information system market. Europe is also likely to
make a vital contribution to the global oncology information system
market over the 2017-2022 forecast period, with the region expected
to present an absolute opportunity of US$212.5 mn in the
aforementioned period.
Developing regions such as Asia Pacific except Japan are likely to be
major contributors to the global oncology information system market
in the future, though their share in the global market is likely to
be limited in the forecast period due to the lack of skilled workers
and technological support required for advanced oncology information
systems. However, the rising prevalence of cancer in leading
economies such as China and India, where government support as well
as private investment in the healthcare sector has grown rapidly in
recent years, is likely to drive the oncology information system
market in the region in the coming years. The APEJ oncology
information system market is expected to gain 100 BPS over its 2017
valuation by 2022, demonstrating its role as a major future component
of the global oncology information system market.
Report Overview @
https://www.transparencymarketresearch.com/oncology-information-system-market.html
Leading players in the global oncology information system market
include Accuray Inc., Koninklijke Philips N.V., Cerner Corporation,
Mckesson Corporation, Flatiron Health Inc., Raysearch Laboratories,
Epic Systems Corporation, Verian Medical Systems Inc., and Elekta
AB.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment